INFINITI® CYP2C19
Product Design
  • The INFINITI® CYP2C19 Assay is available as an in-vitro diagnostic assay, (IVD) in Single and Quad formats.

  • The INFINITI® CYP2C19 Assay is indicated for use as an aid to clinicians in determining therapeutic strategy for therapeutics that are metabolized by the CYP450 2C19 gene product, specifically *2, *3, *17.

  • The INFINITI® CYP2C19 Assay is not indicated to be used to predict drug response or non-response.

  • The INFINITI® CYP2C19 Assay utilizes the CYP2C19 Intellipac®, CYP2C19 Amp Mix and CYP2C19 BioFilmChip® Microarray.

  • The INFINITI® CYP2C19 Assay is automated by the INFINITI® Analyzer


Benefits


Versatility
Multiplexed determination of 3 genetic variants on one BioFilmChip Microarray
 
Efficiency
Customized reports
Agility
Load and Go automation with the INFINITI Analyzer
Integrity
Replicate determinations on a single BioFilmChip Microarray ensure quality results


Genetic Variants
*2 (19154G>A) *3 (17948G>A) *17 (-806C>T)


Genetic Variance
0.2 - 2.0ml of Peripheral whole blood in EDTA (purple-top) tube
50 ng DNA / reaction


Product Information
 
Product No.
Product Name
Description
Pack Size
03 122
03 222
03 322
03 123
03 223
03 323
INFINITI CYP2C19 BioFilmChip
INFINITI CYP2C19 Intellipac
INFINITI CYP2C19 Amp Mix
INFINITI CYP2C19 (Quad Format) BioFilmChip
INFINITI CYP2C19 (Quad Format) Intellipac
INFINITI CYP2C19 (Quad Format) Amp Mix
12 BioFilmChips/Magazine
24 tests/Intellipac
250 ul/vial
12 BioFilmChips/Magazine
96 tests/Intellipac
500 ul/vial
4 magazines/pack
2 Intellipac/pack
4 vials/pack
4 magazines/pack
2 Intellipac/pack
4 vials/pack

Please contact AutoGenomics to obtain product information.